723 related articles for article (PubMed ID: 22740590)
21. Validation of a new Aspergillus real-time PCR assay for direct detection of Aspergillus and azole resistance of Aspergillus fumigatus on bronchoalveolar lavage fluid.
Chong GL; van de Sande WW; Dingemans GJ; Gaajetaan GR; Vonk AG; Hayette MP; van Tegelen DW; Simons GF; Rijnders BJ
J Clin Microbiol; 2015 Mar; 53(3):868-74. PubMed ID: 25568431
[TBL] [Abstract][Full Text] [Related]
22. Assessment of Aspergillus-specific PCR as a screening method for invasive aspergillosis in paediatric cancer patients and allogeneic haematopoietic stem cell recipients with suspected infections.
Reinwald M; Konietzka CA; Kolve H; Uhlenbrock S; Ahlke E; Hummel M; Spiess B; Hofmann WK; Buchheidt D; Groll AH
Mycoses; 2014 Sep; 57(9):537-43. PubMed ID: 24655146
[TBL] [Abstract][Full Text] [Related]
23. Galactomannan in bronchoalveolar lavage for diagnosing invasive fungal disease.
Affolter K; Tamm M; Jahn K; Halter J; Passweg J; Hirsch HH; Stolz D
Am J Respir Crit Care Med; 2014 Aug; 190(3):309-17. PubMed ID: 25007380
[TBL] [Abstract][Full Text] [Related]
24. Aspergillus specific nested PCR from the site of infection is superior to testing concurrent blood samples in immunocompromised patients with suspected invasive aspergillosis.
Boch T; Spiess B; Heinz W; Cornely OA; Schwerdtfeger R; Hahn J; Krause SW; Duerken M; Bertz H; Reuter S; Kiehl M; Claus B; Deckert PM; Hofmann WK; Buchheidt D; Reinwald M
Mycoses; 2019 Nov; 62(11):1035-1042. PubMed ID: 31402465
[TBL] [Abstract][Full Text] [Related]
25. Prospective multicentre PCR-based Aspergillus DNA screening in high-risk patients with and without primary antifungal mould prophylaxis.
Springer J; Lackner M; Nachbaur D; Girschikofsky M; Risslegger B; Mutschlechner W; Fritz J; Heinz WJ; Einsele H; Ullmann AJ; Löffler J; Lass-Flörl C
Clin Microbiol Infect; 2016 Jan; 22(1):80-86. PubMed ID: 26400571
[TBL] [Abstract][Full Text] [Related]
26. Prospective monitoring for invasive aspergillosis using galactomannan and polymerase chain reaction in high risk pediatric patients.
Armenian SH; Nash KA; Kapoor N; Franklin JL; Gaynon PS; Ross LA; Hoffman JA
J Pediatr Hematol Oncol; 2009 Dec; 31(12):920-6. PubMed ID: 19855303
[TBL] [Abstract][Full Text] [Related]
27. Diagnosis of invasive aspergillosis in lung transplant recipients by detection of galactomannan in the bronchoalveolar lavage fluid.
Pasqualotto AC; Xavier MO; Sánchez LB; de Oliveira Costa CD; Schio SM; Camargo SM; Camargo JJ; Sukiennik TC; Severo LC
Transplantation; 2010 Aug; 90(3):306-11. PubMed ID: 20548265
[TBL] [Abstract][Full Text] [Related]
28. Utility of bronchoalveolar lavage fluid galactomannan alone or in combination with PCR for the diagnosis of invasive aspergillosis in adult hematology patients: a systematic review and meta-analysis.
Heng SC; Morrissey O; Chen SC; Thursky K; Manser RL; Nation RL; Kong DC; Slavin M
Crit Rev Microbiol; 2015 Feb; 41(1):124-34. PubMed ID: 23799871
[TBL] [Abstract][Full Text] [Related]
29. Diagnosis of invasive pulmonary aspergillosis in children with bronchoalveolar lavage galactomannan.
de Mol M; de Jongste JC; van Westreenen M; Merkus PJ; de Vries AH; Hop WC; Warris A; Janssens HM
Pediatr Pulmonol; 2013 Aug; 48(8):789-96. PubMed ID: 22949309
[TBL] [Abstract][Full Text] [Related]
30. Impact of PCR-based diagnosis of invasive pulmonary aspergillosis on clinical outcome.
Hardak E; Yigla M; Avivi I; Fruchter O; Sprecher H; Oren I
Bone Marrow Transplant; 2009 Nov; 44(9):595-9. PubMed ID: 19308034
[TBL] [Abstract][Full Text] [Related]
31. Sensitivity of galactomannan enzyme immunoassay for diagnosing breakthrough invasive aspergillosis under antifungal prophylaxis and empirical therapy.
Hoenigl M; Seeber K; Koidl C; Buzina W; Wölfler A; Duettmann W; Wagner J; Strenger V; Krause R
Mycoses; 2013 Jul; 56(4):471-6. PubMed ID: 23432536
[TBL] [Abstract][Full Text] [Related]
32. Diagnosis of invasive aspergillosis in hematological malignancy patients: Performance of cytokines, Asp LFD, and Aspergillus PCR in same day blood and bronchoalveolar lavage samples.
Heldt S; Prattes J; Eigl S; Spiess B; Flick H; Rabensteiner J; Johnson G; Prüller F; Wölfler A; Niedrist T; Boch T; Neumeister P; Strohmaier H; Krause R; Buchheidt D; Hoenigl M
J Infect; 2018 Sep; 77(3):235-241. PubMed ID: 29972764
[TBL] [Abstract][Full Text] [Related]
33. Clinical utility and prognostic value of galactomannan in neutropenic patients with invasive aspergillosis.
Hadrich I; Makni F; Cheikhrouhou F; Neji S; Amouri I; Sellami H; Trabelsi H; Bellaaj H; Elloumi M; Ayadi A
Pathol Biol (Paris); 2012 Dec; 60(6):357-61. PubMed ID: 22154334
[TBL] [Abstract][Full Text] [Related]
34. Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid.
Musher B; Fredricks D; Leisenring W; Balajee SA; Smith C; Marr KA
J Clin Microbiol; 2004 Dec; 42(12):5517-22. PubMed ID: 15583275
[TBL] [Abstract][Full Text] [Related]
35. Bronchogenic carcinoma and secondary aspergillosis--common yet unexplored: evaluation of the role of bronchoalveolar lavage-polymerase chain reaction and some nonvalidated serologic methods to establish early diagnosis.
Shahid M; Malik A; Bhargava R
Cancer; 2008 Aug; 113(3):547-58. PubMed ID: 18521930
[TBL] [Abstract][Full Text] [Related]
36. Correlation between high-resolution computed tomography and galactomannan antigenemia in adult hematologic patients at risk for invasive aspergillosis.
Hidalgo A; Parody R; Martino R; Sánchez F; Franquet T; Giménez A; Blancas C
Eur J Radiol; 2009 Jul; 71(1):55-60. PubMed ID: 18468830
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic accuracy of the Aspergillus-specific bronchoalveolar lavage lateral-flow assay in haematological malignancy patients.
Prattes J; Lackner M; Eigl S; Reischies F; Raggam RB; Koidl C; Flick H; Wurm R; Palfner M; Wölfler A; Neumeister P; Thornton CR; Krause R; Lass-Flörl C; Hoenigl M
Mycoses; 2015 Aug; 58(8):461-9. PubMed ID: 26103209
[TBL] [Abstract][Full Text] [Related]
38. Aspergillus PCR testing: results from a prospective PCR study within the AmBiLoad trial.
Hummel M; Spiess B; Cornely OA; Dittmer M; Mörz H; Buchheidt D
Eur J Haematol; 2010 Aug; 85(2):164-9. PubMed ID: 20374275
[TBL] [Abstract][Full Text] [Related]
39. Clinical evaluation of a polymerase chain reaction assay to detect Aspergillus species in bronchoalveolar lavage samples of neutropenic patients.
Buchheidt D; Baust C; Skladny H; Baldus M; Bräuninger S; Hehlmann R
Br J Haematol; 2002 Mar; 116(4):803-11. PubMed ID: 11886384
[TBL] [Abstract][Full Text] [Related]
40. Aspergillus-PCR in bronchoalveolar lavage for detection of invasive pulmonary aspergillosis in immunocompromised patients.
Buess M; Cathomas G; Halter J; Junker L; Grendelmeier P; Tamm M; Stolz D
BMC Infect Dis; 2012 Oct; 12():237. PubMed ID: 23031334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
